#Product Trends
HEPA 14 Mobile air purifier DOPAIR 1000
Medical grade HEPA 14 Air purifier
Product Made In France:
ATA Launch in 2022 his newly DOPAIR 1000 Mobile air purifier equipped of HEPA14 filter in order to easily decontaminate rooms in medical area.
The DOPAIR 1000® is a mobile air filtration and decontamination unit for high-risk areas in Hospitals. Immediately operational it does not require any modification of the environment to start up.
The unit controls the risks of bacteriological and microbiological contamination and achieve the performance expected for risk zones 2 or 3 (ISO8 or ISO7) according to the ISO 14644-1 and NFS 90-351 standards.
DOPAIR 1000 fights against nosocomial infections thanks to the combined action of three effects: filtration (HEPA14 filter), the Bioxigen® air decontamination module and an appropriate Air Change Rate (air flow up to 1000 m3/h)
DOPAIR 1000 is very efficient to reach a microbiological class close to zero and is designed for use in a room, 24/7. Ergonomic thanks to its 4 wheels, it can be easily moved by medical staff.
Medical Mobile air purifier CE certified.
INTERNAL EQUIPMENTS:
- Pre-filter
- Active Carbon filter
- HEPA14 filter for ultra fine particle
- Destruction of microorganisms via the Bioxigen® module working with Cold Plasma technology (BiPolar Ionization)
- VOC sensor
- Particle sensor
- Hr% / T°C Probe
- Remote control by smart phone
Air flow up to 1000 m3/h
Touch screen control panel (Working Modes, Filter clogging alarms...)
Low sound level: 44 dB(A) at 500 m3/h
“Plug & Play” solution to be installed in the treated area
Control by mobile app
Easy maintenance
Filter clogging alarm
Automatic mode : The airflow increase according to the number of particles detected
EXAMPLES OF AREAS OF APPLICATION:
Operating room
Oncology
Pediatrics
ICU Intensive Care Unit
Gynecology
OPD
Hematology
Chemotherapy
Resuscitation rooms
Plastic surgery
Burn ward
Corridor
Hospital entrance, offices
Annex room
Sterile storage room
Laboratories
Don’t hesitate to contact us for further information.
